Industrial - Infrastructure Operations
Compare Stocks
5 / 10Stock Comparison
ACA vs CAT vs MLM vs VMC vs NUE
Revenue, margins, valuation, and 5-year total return — side by side.
Agricultural - Machinery
Construction Materials
Construction Materials
Steel
ACA vs CAT vs MLM vs VMC vs NUE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Industrial - Infrastructure Operations | Agricultural - Machinery | Construction Materials | Construction Materials | Steel |
| Market Cap | $6.10B | $413.32B | $33.69B | $34.75B | $51.71B |
| Revenue (TTM) | $2.82B | $70.75B | $6.55B | $8.05B | $34.16B |
| Net Income (TTM) | $223M | $9.42B | $2.53B | $1.12B | $2.33B |
| Gross Margin | 22.8% | 32.5% | 29.6% | 27.6% | 14.0% |
| Operating Margin | 10.1% | 16.6% | 22.7% | 20.6% | 10.0% |
| Forward P/E | 29.1x | 36.2x | 29.1x | 29.1x | 15.9x |
| Total Debt | $1.52B | $43.33B | $5.32B | $5.41B | $7.12B |
| Cash & Equiv. | $215M | $9.98B | $67M | $183M | $2.26B |
ACA vs CAT vs MLM vs VMC vs NUE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Arcosa, Inc. (ACA) | 100 | 325.2 | +225.2% |
| Caterpillar Inc. (CAT) | 100 | 739.5 | +639.5% |
| Martin Marietta Mat… (MLM) | 100 | 290.8 | +190.8% |
| Vulcan Materials Co… (VMC) | 100 | 247.3 | +147.3% |
| Nucor Corporation (NUE) | 100 | 537.2 | +437.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ACA vs CAT vs MLM vs VMC vs NUE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ACA ranks third and is worth considering specifically for growth exposure.
- Rev growth 12.2%, EPS growth 122.0%, 3Y rev CAGR 8.7%
- 12.2% revenue growth vs MLM's 0.1%
CAT is the clearest fit if your priority is long-term compounding.
- 12.2% 10Y total return vs ACA's 5.1%
- +155.7% vs VMC's -0.5%
MLM has the current edge in this matchup, primarily because of its strength in sleep-well-at-night.
- Lower volatility, beta 0.90, Low D/E 53.0%, current ratio 3.57x
- 38.7% margin vs NUE's 6.8%
- 13.3% ROA vs ACA's 4.5%, ROIC 7.6% vs 6.4%
VMC is the clearest fit if your priority is defensive.
- Beta 0.86, yield 0.7%, current ratio 2.69x
- Beta 0.86 vs CAT's 1.58, lower leverage
NUE is the #2 pick in this set and the best alternative if income & stability and valuation efficiency is your priority.
- Dividend streak 15 yrs, beta 1.03, yield 1.0%
- PEG 0.61 vs MLM's 2.84
- Lower P/E (15.9x vs 29.1x), PEG 0.61 vs 2.84
- 1.0% yield, 15-year raise streak, vs VMC's 0.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.2% revenue growth vs MLM's 0.1% | |
| Value | Lower P/E (15.9x vs 29.1x), PEG 0.61 vs 2.84 | |
| Quality / Margins | 38.7% margin vs NUE's 6.8% | |
| Stability / Safety | Beta 0.86 vs CAT's 1.58, lower leverage | |
| Dividends | 1.0% yield, 15-year raise streak, vs VMC's 0.7% | |
| Momentum (1Y) | +155.7% vs VMC's -0.5% | |
| Efficiency (ROA) | 13.3% ROA vs ACA's 4.5%, ROIC 7.6% vs 6.4% |
ACA vs CAT vs MLM vs VMC vs NUE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ACA vs CAT vs MLM vs VMC vs NUE — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CAT leads in 2 of 6 categories
NUE leads 1 • ACA leads 0 • MLM leads 0 • VMC leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — CAT and MLM each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CAT is the larger business by revenue, generating $70.8B annually — 25.1x ACA's $2.8B. MLM is the more profitable business, keeping 38.7% of every revenue dollar as net income compared to NUE's 6.8%. On growth, CAT holds the edge at +22.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.8B | $70.8B | $6.6B | $8.1B | $34.2B |
| EBITDAEarnings before interest/tax | $456M | $14.0B | $2.1B | $2.4B | $4.9B |
| Net IncomeAfter-tax profit | $223M | $9.4B | $2.5B | $1.1B | $2.3B |
| Free Cash FlowCash after capex | $225M | $11.4B | $1.0B | $1.1B | $532M |
| Gross MarginGross profit ÷ Revenue | +22.8% | +32.5% | +29.6% | +27.6% | +14.0% |
| Operating MarginEBIT ÷ Revenue | +10.1% | +16.6% | +22.7% | +20.6% | +10.0% |
| Net MarginNet income ÷ Revenue | +7.9% | +13.3% | +38.7% | +13.9% | +6.8% |
| FCF MarginFCF ÷ Revenue | +8.0% | +16.2% | +15.8% | +13.9% | +1.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -9.5% | +22.2% | +0.7% | +7.4% | +21.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -37.5% | +30.2% | +12.2% | +29.9% | +3.8% |
Valuation Metrics
Evenly matched — ACA and NUE each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 29.3x trailing earnings, ACA trades at a 38% valuation discount to CAT's 47.2x P/E. Adjusting for growth (PEG ratio), NUE offers better value at 1.16x vs MLM's 2.90x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $6.1B | $413.3B | $33.7B | $34.8B | $51.7B |
| Enterprise ValueMkt cap + debt − cash | $7.4B | $446.7B | $38.9B | $40.0B | $56.6B |
| Trailing P/EPrice ÷ TTM EPS | 29.28x | 47.18x | 29.72x | 32.98x | 30.19x |
| Forward P/EPrice ÷ next-FY EPS est. | 29.15x | 36.22x | 29.09x | 29.06x | 15.88x |
| PEG RatioP/E ÷ EPS growth rate | 2.06x | 1.68x | 2.90x | 2.52x | 1.16x |
| EV / EBITDAEnterprise value multiple | 13.15x | 33.16x | 18.04x | 17.16x | 13.67x |
| Price / SalesMarket cap ÷ Revenue | 2.11x | 6.12x | 5.15x | 4.38x | 1.59x |
| Price / BookPrice ÷ Book value/share | 2.32x | 19.54x | 3.37x | 4.13x | 2.37x |
| Price / FCFMarket cap ÷ FCF | 34.73x | 40.23x | 34.45x | 30.61x | — |
Profitability & Efficiency
CAT leads this category, winning 3 of 9 comparable metrics.
Profitability & Efficiency
CAT delivers a 47.5% return on equity — every $100 of shareholder capital generates $48 in annual profit, vs $9 for ACA. NUE carries lower financial leverage with a 0.32x debt-to-equity ratio, signaling a more conservative balance sheet compared to CAT's 2.03x. On the Piotroski fundamental quality scale (0–9), VMC scores 9/9 vs CAT's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +8.6% | +47.5% | +25.1% | +13.1% | +10.6% |
| ROA (TTM)Return on assets | +4.5% | +10.0% | +13.3% | +6.6% | +6.7% |
| ROICReturn on invested capital | +6.4% | +15.9% | +7.6% | +8.8% | +7.7% |
| ROCEReturn on capital employed | +7.8% | +19.1% | +8.7% | +10.1% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 5 | 7 | 9 | 7 |
| Debt / EquityFinancial leverage | 0.58x | 2.03x | 0.53x | 0.63x | 0.32x |
| Net DebtTotal debt minus cash | $1.3B | $33.4B | $5.3B | $5.2B | $4.9B |
| Cash & Equiv.Liquid assets | $215M | $10.0B | $67M | $183M | $2.3B |
| Total DebtShort + long-term debt | $1.5B | $43.3B | $5.3B | $5.4B | $7.1B |
| Interest CoverageEBIT ÷ Interest expense | 2.76x | 9.22x | 6.44x | 4.13x | 29.72x |
Total Returns (Dividends Reinvested)
CAT leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CAT five years ago would be worth $37,356 today (with dividends reinvested), compared to $14,322 for VMC. Over the past 12 months, CAT leads with a +155.7% total return vs VMC's -0.5%. The 3-year compound annual growth rate (CAGR) favors CAT at 62.4% vs VMC's 11.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +16.3% | +48.9% | -11.8% | -8.3% | +34.3% |
| 1-Year ReturnPast 12 months | +40.8% | +155.7% | +1.6% | -0.5% | +98.5% |
| 3-Year ReturnCumulative with dividends | +81.8% | +328.4% | +40.4% | +39.4% | +66.2% |
| 5-Year ReturnCumulative with dividends | +100.9% | +273.6% | +52.4% | +43.2% | +123.2% |
| 10-Year ReturnCumulative with dividends | +509.7% | +1218.7% | +212.3% | +143.0% | +412.8% |
| CAGR (3Y)Annualised 3-year return | +22.0% | +62.4% | +12.0% | +11.7% | +18.5% |
Risk & Volatility
Evenly matched — VMC and NUE each lead in 1 of 2 comparable metrics.
Risk & Volatility
VMC is the less volatile stock with a 0.86 beta — it tends to amplify market swings less than CAT's 1.58 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NUE currently trades 96.4% from its 52-week high vs MLM's 78.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.42x | 1.58x | 0.90x | 0.86x | 1.03x |
| 52-Week HighHighest price in past year | $135.58 | $931.35 | $710.97 | $331.09 | $235.45 |
| 52-Week LowLowest price in past year | $81.91 | $336.24 | $532.80 | $252.35 | $106.21 |
| % of 52W HighCurrent price vs 52-week peak | +91.6% | +95.4% | +78.6% | +80.9% | +96.4% |
| RSI (14)Momentum oscillator 0–100 | 64.3 | 66.5 | 34.7 | 38.4 | 73.8 |
| Avg Volume (50D)Average daily shares traded | 286K | 2.3M | 466K | 1.1M | 1.3M |
Analyst Outlook
NUE leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ACA as "Buy", CAT as "Buy", MLM as "Buy", VMC as "Buy", NUE as "Buy". Consensus price targets imply 24.8% upside for MLM (target: $697) vs -2.4% for CAT (target: $867). For income investors, NUE offers the higher dividend yield at 0.98% vs ACA's 0.16%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $140.00 | $867.33 | $697.40 | $327.00 | $222.83 |
| # AnalystsCovering analysts | 8 | 53 | 40 | 36 | 32 |
| Dividend YieldAnnual dividend ÷ price | +0.2% | +0.7% | +0.6% | +0.7% | +1.0% |
| Dividend StreakConsecutive years of raises | 1 | 8 | 11 | 12 | 15 |
| Dividend / ShareAnnual DPS | $0.20 | $5.86 | $3.26 | $1.97 | $2.22 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.3% | +1.3% | +1.3% | +1.4% |
CAT leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). NUE leads in 1 (Analyst Outlook). 3 tied.
ACA vs CAT vs MLM vs VMC vs NUE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ACA or CAT or MLM or VMC or NUE a better buy right now?
For growth investors, Arcosa, Inc.
(ACA) is the stronger pick with 12. 2% revenue growth year-over-year, versus 0. 1% for Martin Marietta Materials, Inc. (MLM). Arcosa, Inc. (ACA) offers the better valuation at 29. 3x trailing P/E (29. 1x forward), making it the more compelling value choice. Analysts rate Arcosa, Inc. (ACA) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ACA or CAT or MLM or VMC or NUE?
On trailing P/E, Arcosa, Inc.
(ACA) is the cheapest at 29. 3x versus Caterpillar Inc. at 47. 2x. On forward P/E, Nucor Corporation is actually cheaper at 15. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Nucor Corporation wins at 0. 61x versus Martin Marietta Materials, Inc. 's 2. 84x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — ACA or CAT or MLM or VMC or NUE?
Over the past 5 years, Caterpillar Inc.
(CAT) delivered a total return of +273. 6%, compared to +43. 2% for Vulcan Materials Company (VMC). Over 10 years, the gap is even starker: CAT returned +1219% versus VMC's +143. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ACA or CAT or MLM or VMC or NUE?
By beta (market sensitivity over 5 years), Vulcan Materials Company (VMC) is the lower-risk stock at 0.
86β versus Caterpillar Inc. 's 1. 58β — meaning CAT is approximately 84% more volatile than VMC relative to the S&P 500. On balance sheet safety, Nucor Corporation (NUE) carries a lower debt/equity ratio of 32% versus 2% for Caterpillar Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ACA or CAT or MLM or VMC or NUE?
By revenue growth (latest reported year), Arcosa, Inc.
(ACA) is pulling ahead at 12. 2% versus 0. 1% for Martin Marietta Materials, Inc. (MLM). On earnings-per-share growth, the picture is similar: Arcosa, Inc. grew EPS 122. 0% year-over-year, compared to -42. 0% for Martin Marietta Materials, Inc.. Over a 3-year CAGR, ACA leads at 8. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ACA or CAT or MLM or VMC or NUE?
Martin Marietta Materials, Inc.
(MLM) is the more profitable company, earning 17. 4% net margin versus 5. 4% for Nucor Corporation — meaning it keeps 17. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MLM leads at 23. 3% versus 8. 2% for NUE. At the gross margin level — before operating expenses — CAT leads at 32. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ACA or CAT or MLM or VMC or NUE more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Nucor Corporation (NUE) is the more undervalued stock at a PEG of 0. 61x versus Martin Marietta Materials, Inc. 's 2. 84x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Nucor Corporation (NUE) trades at 15. 9x forward P/E versus 36. 2x for Caterpillar Inc. — 20. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MLM: 24. 8% to $697. 40.
08Which pays a better dividend — ACA or CAT or MLM or VMC or NUE?
All stocks in this comparison pay dividends.
Nucor Corporation (NUE) offers the highest yield at 1. 0%, versus 0. 2% for Arcosa, Inc. (ACA).
09Is ACA or CAT or MLM or VMC or NUE better for a retirement portfolio?
For long-horizon retirement investors, Caterpillar Inc.
(CAT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (0. 7% yield, +1219% 10Y return). Both have compounded well over 10 years (CAT: +1219%, ACA: +509. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ACA and CAT and MLM and VMC and NUE?
These companies operate in different sectors (ACA (Industrials) and CAT (Industrials) and MLM (Basic Materials) and VMC (Basic Materials) and NUE (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
CAT, MLM, VMC, NUE pay a dividend while ACA does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.